163
Views
0
CrossRef citations to date
0
Altmetric
Special Report

Uropathogenic Escherichia Coli Infection: Potential Importance of Epigenetics

&
Pages 229-235 | Published online: 27 Mar 2012

References

  • Freedman AL . Urologic Diseases in America. Litwin MS, Saigal CS (Eds). US department of health and human services, public health service, national institutes of health, national institute of diabetes and digestive and kidney diseases. Washington, DC, USA (2007).
  • Mangiarotti P , PizziniC, FanosV. Antibiotic prophylaxis in children with relapsing urinary tract infections: review. J. Chemother.12(2) , 115–123 (2000).
  • Jantunen ME , SaxenH, SaloE, SiitonenA. Recurrent urinary tract infections in infancy: relapses or reinfections? J. Infect. Dis.185(3) , 375–379 (2002).
  • Mattoo TK . Vesicoureteral reflux and reflux nephropathy. Adv. Chronic Kidney Dis.18(5) , 348–354 (2011).
  • Avlan D , GundogduG, TaskinlarH, DelibasA, NayciA. Relationships among vesicoureteric reflux, urinary tract infection and renal injury in children with non-neurogenic lower urinary tract dysfunction. J. Pediatr. Urol.7(6) , 612–615 (2011).
  • Mulvey MA , Lopez-BoadoYS, WilsonCL et al. Induction and evasion of host defenses by Type 1-piliated uropathogenic Escherichia coli. Science 282(5393) , 1494–1497 (1998).
  • Zhou G , MoWJ, SebbelP et al. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J. Cell Sci. 114(Pt 22) , 4095–4103 (2001).
  • Mak RH , KuoHJ. Pathogenesis of urinary tract infection: an update. Curr. Opin. Pediatr.18(2) , 148–152 (2006).
  • Ragnarsdottir B , LutayN, Gronberg-HernandezJ, KovesB, SvanborgC. Genetics of innate immunity and UTI susceptibility. Nat. Rev. Urol.8(8) , 449–468 (2011).
  • Weichhart T , HaidingerM, HorlWH, SaemannMD. Current concepts of molecular defence mechanisms operative during urinary tract infection. Eur. J. Clin. Invest.38(Suppl. 2) , 29–38 (2008).
  • Berry RE , KlumppDJ, SchaefferAJ. Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect. Immun.77(7) , 2762–2772 (2009).
  • Nielubowicz GR , MobleyHL. Host–pathogen interactions in urinary tract infection. Nat. Rev. Urol.7(8) , 430–441 (2010).
  • Hawn TR , ScholesD, WangH et al. Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women. PLoS ONE 4(12) , e8300 (2009).
  • Zaffanello M , MalerbaG, CataldiL et al. Genetic risk for recurrent urinary tract infections in humans: a systematic review. J. Biomed. Biotechnol. 2010 , 321082 (2010).
  • Hannan TJ , MysorekarIU, HungCS, Isaacson-SchmidML, HultgrenSJ. Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog.6(8) , e1001042 (2010).
  • Shin K , LeeJ, GuoN et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472(7341) , 110–114 (2011).
  • Tasian G , CunhaG, BaskinL. Smooth muscle differentiation and patterning in the urinary bladder. Differentiation80(2–3) , 106–117 (2010).
  • Gutierrez MI , SirajAK, KhaledH, KoonN, El-RifaiW, BhatiaK. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod. Pathol.17(10) , 1268–1274 (2004).
  • Stein RA . Epigenetics – the link between infectious diseases and cancer. JAMA305(14) , 1484–1485 (2011).
  • Niwa T , TsukamotoT, ToyodaT et al. Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 70(4) , 1430–1440 (2010).
  • Niwa T , UshijimaT. Induction of epigenetic alterations by chronic inflammation and its significance on carcinogenesis. Adv. Genet.71 , 41–56 (2010).
  • Wolff EM , ChiharaY, PanF et al. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. Cancer Res. 70(20) , 8169–8178 (2010).
  • Kovalenko VM , BagnyukovaTV, SergienkoOV et al. Epigenetic changes in the rat livers induced by pyrazinamide treatment. Toxicol. Appl. Pharmacol. 225(3) , 293–299 (2007).
  • Tolg C , SabhaN, CorteseR et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab. Invest. 91(6) , 825–836 (2011).
  • Tatemichi M , HataH, TazawaH, NakadateT. Lipopolysaccharide induces aberrant hypermethylation of Hic-1 in mouse embryonic fibroblasts lacking p53 gene. Anticancer Res.28(4B) , 2101–2108 (2008).
  • Yin X , HouT, LiuY et al. Association of Toll-like receptor 4 gene polymorphism and expression with urinary tract infection types in adults. PLoS ONE 5(12) , e14223 (2010).
  • Ragnarsdottir B , JonssonK, UrbanoA et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS ONE 5(5) , e10734 (2010).
  • Takahashi K , SugiY, HosonoA, KaminogawaS. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J. Immunol.183(10) , 6522–6529 (2009).
  • Suhs KA , MarthalerBR, WelchRA, HopkinsWJ. Lack of association between the Tlr4 (Lpsd/Lpsd) genotype and increased susceptibility to Escherichia coli bladder infections in female C3H/HeJ mice. MBio2(3) , e00094–e00011 (2011).
  • Schulz WA . Uropathogenic bacteria leave a mark. Lab. Invest.91(6) , 816–818 (2011).
  • Verdoodt B , SommererF, PalisaarRJ et al. Inverse association of p16(INK4a) and p14(ARF) methylation of the CDKN2a locus in different Gleason scores of prostate cancer. Prostate Cancer Prostatic. Dis. 14(4) , 295–301 (2011).
  • Sterlacci W , TzankovA, VeitsL et al. A comprehensive analysis of p16 expression, gene status, and promoter hypermethylation in surgically resected non-small cell lung carcinomas. J. Thorac. Oncol. 6(10) , 1649–1657 (2011).
  • Miyamoto K , UshijimaT. Diagnostic and therapeutic applications of epigenetics. Jpn. J. Clin. Oncol.35(6) , 293–301 (2005).
  • Phe V , CussenotO, RoupretM. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract. BJU Int.104(7) , 896–901 (2009).
  • Friedrich MG , WeisenbergerDJ, ChengJC et al. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients. Clin. Cancer Res. 10(22) , 7457–7465 (2004).
  • Costa VL , HenriqueR, DanielsenSA et al. TCF21 and PCDH17 methylation: an innovative panel of biomarkers for a simultaneous detection of urological cancers. Epigenetics doi:10.4161/epi.6.9.16376 (2011) (Epub ahead of print).
  • Haruki S , ImotoI, KozakiK et al. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis 31(6) , 1027–1036 (2010).
  • Reinert T , ModinC, CastanoFM et al. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers. Clin. Cancer Res. 17(17) , 5582–5592 (2011).
  • Hansen KD , TimpW, BravoHC et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43(8) , 768–775 (2011).

▪ Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.